Liver‐Expressed Antimicrobial Peptide 2 antagonizes the insulinostatic effect of ghrelin in rat isolated pancreatic islets

The ups and downs of growth hormone secretagogue receptor signaling

(2021) María P Cornejo et al.   FEBS Journal

Development of Nonpeptidic Inverse Agonists of the Ghrelin Receptor (GHSR) Based on the 1,2,4-Triazole Scaffold

(2020) Khoubaib Ben Haj Salah et al.   JOURNAL OF MEDICINAL CHEMISTRY

Identifying the binding mechanism of LEAP2 to receptor GHSR1a

(2019) Jia-Hui Wang et al.   FEBS Journal

The Ellagitannin Metabolite Urolithin C is a Glucose‐Dependent Regulator of Insulin Secretion through L‐type Calcium Channel Activation

(2019) Morgane Bayle et al.   BRITISH JOURNAL OF PHARMACOLOGY

LEAP2 changes with body mass and food intake in humans and mice

(2019) Bharath K. Mani et al.   JOURNAL OF CLINICAL INVESTIGATION

Liver-expressed antimicrobial peptide 2 antagonizes the effect of ghrelin in rodents

(2019) Md Nurul Islam et al.   JOURNAL OF ENDOCRINOLOGY

The Homeostatic Force of Ghrelin

(2018) Shigehisa Yanagi et al.   Cell Metabolism

LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor

(2018) Xuecai Ge et al.   Cell Metabolism

N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) Region Exhibits Inverse Agonist Activity toward the Ghrelin Receptor

(2018) Céline M’Kadmi et al.   JOURNAL OF MEDICINAL CHEMISTRY

Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets

(2016) Michael R. DiGruccio et al.   Molecular Metabolism